PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Colistimethate sodium - Bronchiectasis

PAD Profile : Colistimethate sodium - Bronchiectasis

Keywords :
nebuliser, nebules, Home nebuliser, antibiotic, antibacterial
Brand Names Include :
Colistin, Colomycin,

Traffic Light Status

Status 1 of 1.

Status :
Blue
Important
Formulations :
  • Powder
Important Information :
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialisit microbiology recommendation. Colistimethate sdoium 1million unit powder for solution for injection, infusion, inhalation vials is the most cost effective option for inhalation use by nebulisation.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
R
NICE
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

Additional Documents

Type
Document
Review Date

Committee Recommendations

Date
Committee Name
Narrative
11 November 2010
Not Set
A pathway has been agreed for the use of home nebulised therapy in specific cohorts of patients. The nebuliser and ongoing consumables are supplied direct to the patients home by Philips Respironics. Colomycin powder for injection is a more cost effective alternative to Promixin. The BNF states that Colomycin injection may be used for nebulisation

Associated BNF Codes

05. Infections
05.01.07. Some other antibacterials
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More